Search Patents
-
Patent number: 9994794Abstract: The present invention discloses a method for extracting cinnamon oil; firstly, a cinnamon powder is mixed and conditioned with an aqueous solution of sodium salts, and the conditioned cinnamon powder is obtained thereafter; subsequently, the conditioned cinnamon powder obtained was frozen and then rapidly thawed, and the thawed cinnamon powder is obtained thereafter; finally, after the thawed cinnamon powder is mixed with a gaseous solvent, pressurized liquid extraction is performed, and then after separation the cinnamon oil is obtained. The method for extracting cinnamon oil from cinnamon at a low temperature adds an aqueous solution of sodium salts to condition the cinnamon powder, uses a slow freezing process and a rapid thawing process, and finally uses a gaseous solvent, which may gasify without heating to be separated from the extract; the extraction process is kept away from air, and the heat-sensitive components are not damaged.Type: GrantFiled: August 19, 2016Date of Patent: June 12, 2018Assignee: INFINITUS (CHINA) COMPANY LTD.Inventors: Chung Wah Ma, Fangli Ma, Renhuai Cong, Xiuying Kou, Chuixin Qin
-
Publication number: 20150140135Abstract: A method for promoting weight loss and/or lowering blood glucose comprises an active material which may be cinnamon, an extract of cinnamon, or a derivative of a cinnamon extract. The active material may be utilized in combination with further active ingredients.Type: ApplicationFiled: January 30, 2015Publication date: May 21, 2015Applicant: IN Ingredients, Inc.Inventors: Peter J. Miller, Timothy Romero
-
Patent number: 8895083Abstract: A composition is disclosed which comprises cinnamon or cinnamon extract such as cinnamon aqueous extract TC 112 and panax ginseng or extract from panax ginseng standardized to 1.5 to 7% ginsenosides and may comprise an artificial sweetener. The composition is embodied in the form of a pill or food product with 120 mg of cinnamon aqueous extract and 120 mg of ginseng standardized to 1.5 to 7% ginsenosides. The composition is used as a daily dosage for improvement of cognitive function, prevention or treatment of Alzheimer's disease, maintenance or lowering of blood-sugar levels, prevention of arterial disease or the improvement of cognitive function in diabetics.Type: GrantFiled: October 23, 2009Date of Patent: November 25, 2014Assignee: Allegiance Equity CorporationInventors: David Solomon, Hector J. Gomez
-
Publication number: 20110200692Abstract: The present application disclosed the use of a cinnamon extract in the treatment of amyloid-associated diseases and disorders, such as Alzheimer's disease.Type: ApplicationFiled: October 11, 2009Publication date: August 18, 2011Applicant: RAMOT AT TEL-AVIV UNIVERSITY LTD.Inventors: Michael Ovadia, Ehud Gazit, Anat Frydman-Marom
-
Publication number: 20100098787Abstract: The invention relates to diallyl disulfide and cinnamon oil formulations, for protecting plants from nematodes and other plant pathogens. The invention provides a method for suppressing plant damage by nematodes and other plant pathogens, which comprises the concurrent administration, to the locus, soil or seeds of plants in need of such treatment, of (a) cinnamon oil (and/or its component cinnamaldehyde), (b) an effective quantity of diallyl disulfide, as well as nematocidal compositions useful therein.Type: ApplicationFiled: October 16, 2009Publication date: April 22, 2010Inventors: Benjamin A. BELKIND, Bassam SHAMMO, Rebecca DICKENSON, Linda A. REHBERGER
-
Publication number: 20110212192Abstract: A composition of ingestible ingredients containing a first ingestible ingredient which has an undesired effect on the human body when ingested, wherein preferably the ingredient is sugar and the undesired effect is blood sugar fluctuations which can lead to diabetes, and at least one other ingestible ingredient which reduces the impact or the undesired effect of the first ingestible ingredient, wherein the other ingredient is either cinnamon or polyphenols from cinnamon, or ginseng or ginsenosides from ginseng. The composition may be in a package, a bulk mix or a product.Type: ApplicationFiled: October 23, 2009Publication date: September 1, 2011Applicant: ALLEGIANCE EQUITY CORPORATIONInventors: David Solomon, Hector J. Gomez
-
Publication number: 20120128803Abstract: This invention relates to an improved process for preparing water extract of cinnamon in a large scale. The process comprises the steps of: (a) adding an aqueous solvent such as water to at least 5 kg of a cinnamon raw material at a water to material ratio of 1:1 to 100:1, (b) boiling the mixture of (a) for at least 5 minutes, (c) removing the solid debris from the mixture, (d) storing the liquid portion of the mixture at about ?5 to 25° C., preferably 0-10° C., until a top layer of oil is formed and partitioned, (e) removing the top layer of oil, and (f) collecting the remaining liquid portion. The present process prepares a cinnamon water extract product with a minimal content of potentially toxic cinnamaldehyde and coumarin, while increasing the contents of the active ingredients of polyphenolic polymers for controlling blood glucose level.Type: ApplicationFiled: November 23, 2010Publication date: May 24, 2012Inventors: Nanzheng CHENG, Long LUO, Jiang KONG
-
Publication number: 20120128804Abstract: This invention relates to an improved process for preparing water extract of cinnamon in a large scale. The process comprises the steps of: (a) adding an aqueous solvent such as water to at least 5 kg of a cinnamon raw material at a water to material ratio of 1:1 to 100:1, (b) boiling the mixture of (a) for at least 5 minutes, (c) removing the solid debris from the mixture, (d) storing the liquid portion of the mixture at about ?5 to 25° C., preferably 0-10° C., until a top layer of oil is formed and partitioned, (e) removing the top layer of oil, and (f) collecting the remaining liquid portion. The present process prepares a cinnamon water extract product with a minimal content of potentially toxic cinnamaldehyde and coumarin, while increasing the contents of the active ingredients of polyphenolic polymers for controlling blood glucose level.Type: ApplicationFiled: October 4, 2011Publication date: May 24, 2012Inventors: Nanzheng CHENG, Long LUO, Jiang KONG
-
Patent number: 8304000Abstract: This invention relates to an improved process for preparing water extract of cinnamon in a large scale. The process comprises the steps of: (a) adding an aqueous solvent such as water to at least 5 kg of a cinnamon raw material at a water to material ratio of 1:1 to 100:1, (b) boiling the mixture of (a) for at least 5 minutes, (c) removing the solid debris from the mixture, (d) storing the liquid portion of the mixture at about ?5 to 25° C., preferably 0-10° C., until a top layer of oil is formed and partitioned, (e) removing the top layer of oil, and (f) collecting the remaining liquid portion. The present process prepares a cinnamon water extract product with a minimal content of potentially toxic cinnamaldehyde and coumarin, while increasing the contents of the active ingredients of polyphenolic polymers for controlling blood glucose level.Type: GrantFiled: October 4, 2011Date of Patent: November 6, 2012Assignee: Beijing Tang-An Nutrition & Healthcare Products Co. Ltd.Inventors: Nanzheng Cheng, Long Luo, Jiang Kong
-
Patent number: 8273389Abstract: The invention relates to diallyl disulfide and cinnamon oil formulations, for protecting plants from nematodes and other plant pathogens. The invention provides a method for suppressing plant damage by nematodes and other plant pathogens, which comprises the concurrent administration, to the locus, soil or seeds of plants in need of such treatment, of (a) cinnamon oil (and/or its component cinnamaldehyde), (b) an effective quantity of diallyl disulfide, as well as nematocidal compositions useful therein.Type: GrantFiled: October 16, 2009Date of Patent: September 25, 2012Assignee: Valent BioSciences CorporationInventors: Benjamin A. Belkind, Bassam Shammo, Rebecca Dickenson, Linda A. Rehberger, Daniel F. Heiman
-
Patent number: 8329232Abstract: This invention relates to an improved process for preparing water extract of cinnamon in a large scale. The process comprises the steps of: (a) adding an aqueous solvent such as water to at least 5 kg of a cinnamon raw material at a water to material ratio of 1:1 to 100:1, (b) boiling the mixture of (a) for at least 5 minutes, (c) removing the solid debris from the mixture, (d) storing the liquid portion of the mixture at about ?5 to 25° C., preferably 0-10° C., until a top layer of oil is formed and partitioned, (e) removing the top layer of oil, and (f) collecting the remaining liquid portion. The present process prepares a cinnamon water extract product with a minimal content of potentially toxic cinnamaldehyde and coumarin, while increasing the contents of the active ingredients of polyphenolic polymers for controlling blood glucose level.Type: GrantFiled: November 23, 2010Date of Patent: December 11, 2012Assignee: Beijing Tang-An Nutrition & Healthcare Products Co. Ltd.Inventors: Nanzheng Cheng, Long Luo, Jiang Kong
-
Publication number: 20080299232Abstract: The invention generally relates to various cinnamon oil formulations for protecting plants from nematodes and other pathogens. The invention provides specific formulations which do not require the use of chemical additives. These formulations have low phytotoxicity and low volatility. Also, methods of applying the formulations for agricultural use are disclosed.Type: ApplicationFiled: May 16, 2008Publication date: December 4, 2008Inventors: Yueh Wang, Bassam Shammo, Rebecca Dickenson, John Lopez, Judith Fugiel, Linda Rehberger, Prem Warrior
-
Publication number: 20130287872Abstract: The invention concerns a composition for lowering the glycemic index comprising, or consisting of an alcoholic extract of cinnamon in an amount of at least 10% by weight compared to the total weight of the composition, and optionally a carrier, a food composition comprising a composition for lowering the glycemic index in an amount ranging from 0.1% to 5% by weight compared to the total weight of the food composition, the use of a composition for lowering the glycemic index or of a food composition as a glycemic index lowering agent.Type: ApplicationFiled: December 23, 2011Publication date: October 31, 2013Applicant: DIALPHAInventors: Nicolas Chapal, Vickram Beejmohun
-
Publication number: 20040224035Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.Type: ApplicationFiled: April 12, 2004Publication date: November 11, 2004Inventors: Peter Miller, Timothy Romero
-
Publication number: 20110280973Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.Type: ApplicationFiled: July 21, 2011Publication date: November 17, 2011Applicant: FHG Corporation d/b/a Integrity NutraceuticalsInventors: Peter Miller, Timothy Romero
-
Publication number: 20090191290Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.Type: ApplicationFiled: March 16, 2009Publication date: July 30, 2009Applicant: FHG Corporation d/b/a integrity NutraceuticalsInventors: Peter Miller, Timothy Romero
-
Patent number: 9089577Abstract: This invention relates to methods and compositions for providing improved insulin-sensitivity and/or enhanced insulin-like action, which leads to improved glucose uptake and utilization. The invention provides a method for increasing glucose uptake in a subject. The present invention also provides a method for regulating blood glucose level in a subject. The invention further provides a method for decreasing blood glucose level in a hyperglycemic subject. The methods comprise administering to a subject an effective amount of a water extract of cinnamon and an effective amount of a water extract of Radix Astragali.Type: GrantFiled: July 28, 2014Date of Patent: July 28, 2015Inventor: Nanzheng Cheng
-
Patent number: 7504118Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.Type: GrantFiled: April 12, 2004Date of Patent: March 17, 2009Assignee: FHG CorporationInventors: Peter Miller, Timothy Romero
-
Patent number: 8003141Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.Type: GrantFiled: March 16, 2009Date of Patent: August 23, 2011Assignee: Integrity NutraceuticalsInventors: Peter Miller, Timothy Romero
-
Patent number: 8318221Abstract: Materials derived from cinnamon can be administered orally to humans or animals for the purpose of controlling blood glucose as well improving glucose tolerance. Controlling glucose metabolism is essential for those with impaired glucose metabolism as is the case for those with Type II diabetes where insulin function is not properly functioning. Such administration can also be used for the purpose of enhancing nutrient transport for purposes of athletic performance and controlling bodyweight and body fat levels. Similarly related, such administration can also be used for the purpose of enhancing creatine transport into excitable tissues such as skeletal muscle. The material can be administered as extracts of cinnamon and can be administered in a variety of ways including capsules, tablets, powdered beverages, bars, gels or drinks.Type: GrantFiled: July 21, 2011Date of Patent: November 27, 2012Assignee: FHG CorporationInventors: Peter J. Miller, Timothy Romero